Meghmani Finechem Limited submits herewith transcript of Earnings Conference Call held on 25th April, 2023 for Q4 & FY2023 - Audited Financial Results.

pdf

Epigral Ltd.

27 Apr 2023

1832.00

-1.31%

Corp. Note

Meghmani Finechem Ltd - 543332 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMeghmani Finechem Ltd 2CIN NO.L24100GJ2007PLC051717 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 544.64 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: KAMLESH MEHTA Designation: COMPANY SECRETARY EmailId: kamlesh.mehta@meghmani.com Name of the Chief Financial Officer: SANJAY JAIN Designation: CHIEF FINANCIAL OFFICER EmailId: sanjay.jain@meghmani.com Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Epigral Ltd.

26 Apr 2023

1832.00

-1.31%

Company Update

Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Meghmani Finechem Limited submits herewith newspaper advertisement published on 26th April, 2023 in Economic Times (English edition) and Financial Express (English and Gujarati edition) for Audited Financial Results (Standalone and Consolidated) for fourth quarter and year ended on 31st March, 2023.

pdf

Epigral Ltd.

26 Apr 2023

1832.00

-1.31%

Company Update

Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Meghmani Finechem Limited ('Company') hereby informs that the Company is having One-on-one Meeting with Max Life Insurance Co Ltd on 27th April, 2023.

pdf

VOTE: Is Meghmani Finechem Ltd. worth buying?

90 Votes:

Buy 86.67%

Sell 8.89%

Hold 4.44%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf